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Increasing evidence suggests that adipose-derived stem cells (ADSCs) serve as a therapeutic approach for wound healing. The aim
of this study was to determine the effect of photobiomodulation (PBM) on antioxidant enzymes in ADSCs. Four ADSC cell models,
namely, normal, wounded, diabetic, and diabetic wounded, were irradiated with 660 nm (fluence of 5 J/cm2 and power density of
11.2mW/cm2) or 830 nm (fluence of 5 J/cm2 and power density of 10.3mW/cm2). Nonirradiated cells served as controls. Cell
morphology and wound migration were determined using light microscopy. Cell viability was determined by the trypan blue
exclusion assay. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of antioxidants (superoxide
dismutase (SOD), catalase (CAT), and heme oxygenase (HMOX1)). AKT activation and FOXO1 levels were determined by
immunofluorescence and western blotting. The gaps (wound) in PBM-treated wounded and diabetic wounded cell models
closed faster than the controls. PBM treatment significantly increased antioxidant levels in all cell models. This reflects that
oxidative stress is reduced on the counterpart of increased antioxidant levels. This might be due to the activation of the AKT
signaling pathway as evidenced by the increased AKT signals via western blotting and immunofluorescence. This data suggests
that PBM promotes wound healing by increasing antioxidant levels by activating AKT signaling.
1. Introduction
Nonhealing chronic wounds are a prominent public health
problem, affecting millions of patients worldwide [1].
Delayed healing of chronic wounds is characterized by a
prolonged inflammatory phase, epigenetic changes, delayed
cellular proliferation, poor reepithelialization, and impaired
angiogenesis [2]. Wound healing in the skin is a complicated
process that includes a series of biological events including
cell proliferation and migration, reepithelialization, collagen
deposition, and angiogenesis [3]. Because of limited cell
sources, wound healing is adequately low in larger surface
areas of skin wounds [4].
Increased blood sugar levels (hyperglycemic state) affect
various phases of wound healing through different signaling
mechanisms [5]. Hyperglycemia drastically increases the
expression of proinflammatory cytokines, free radicals, and
reactive oxygen species (ROS) [6], thereby increasing cellular
oxidative stress. Under hyperglycemic conditions, an imbal-
ance in ROS production and antioxidant levels leads to
increased oxidative stress [7, 8]. High levels of ROS/reactive
nitrogen species (RNS) promote oxidation of DNA, lipids,
and proteins which results in cellular damage and cell death.
Apart from cell death, increased ROS promotes cellular
senescence by increasing protein denaturation, lipid peroxi-
dation, DNA modification, and mitochondrial dysfunction
[9, 10]. However, low quantities of ROS are required for
various cell signaling and gene transcription processes, and
only when there is an accumulation of intracellular ROS does
it become deleterious to cells and leads to cell death [11].
Therefore, maintaining a normal redox balance is important
for cell survival and growth.
Osteoblasts, chondrocytes, myocytes, adipocytes, and
skin cells are all differentiated from mesenchymal stem cells
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(MSCs). MSCs are multipotent stromal cells [12]; therefore,
these cells can be an optimal alternative source of cells that
may be used for wound healing in the skin. Adipose-
derived stem cells (ADSCs) are one of the many types of
MSCs and are preferably used in dermatology [13]. A domi-
nant source of MSCs is fat tissue, and the isolation of ADSCs
is easy with a greater cell yield of 100–1,000 times compared
to bone mesenchymal stem cells (BMSCs). ADSCs can par-
ticipate in regeneration processes (through a paracrine effect,
releasing cytokines, and growth factors) directly or indirectly
[14]. Cherubino et al. found that the autologous transplanta-
tion of ADSCs showed an improvement in full thickness graft
survival, scar reduction, and wound healing [15]. In addition,
stem cells are capable of enhancing wound healing processes
by inducing angiogenesis and stimulating collagen deposi-
tion by progressing alone or together with other growth
factors [16].
Many preclinical studies reported the importance of
ADSCs in regulating wound healing mostly by regulating
matrix synthesis and deposition [17]. A study conducted by
Shen and colleagues showed that treatment with artificial der-
mis and ADSCs with poly (L-glutamic acid)/chitosan scaffold
(PLGA) increased new blood vessel formation and fibroblast
proliferation that leads to the formation of a new dermis
[18]. ADSC-treated wounds upregulate genes involved in
matrix deposition that organize the cytoskeleton and provide
a normal remodeling phase [19]. Combination therapy with
growth factors and ADSCs can induce wound closure;
however, the mechanism of growth factor-mediated wound
healing processes is poorly understood.
Photobiomodulation (PBM) is considered a nonpharma-
cological, pain-free treatment option for diabetic foot ulcers,
with positive effects [20–22]. Previous studies from our
group have shown that irradiation of fibroblast cells
(wounded cell model) grown under hyperglycemic condi-
tions (diabetic wounded cells) and irradiated at 632.8 nm
(23mW) with either 5 or 16 J/cm2 showed increased prolifer-
ation and migration at a lower fluence of 5 J/cm2, while cells
exposed to a higher fluence of 16 J/cm2 showed evidence of
cell damage, decreased proliferation, and no cell migration
[23]. It has also been shown that PBM at 636nm (5 J/cm2,
95mW) reduces apoptosis and inflammation (IL-1β), and
at 660nm (92.8mW, 5 J/cm2), there is improved prolifera-
tion, migration, viability, and collagen type I in the same cells
[24, 25]. Hypoxic cells irradiated at 636nm showed an
improvement in cellular morphology, an increase in prolif-
eration, viability, and IL-6, and decreased apoptosis [26].
Both the wavelengths (660 and 830nm) at a fluence of
5 J/cm2 have shown to be the most effective in stimulating
WS1 human skin fibroblast cells, in both wounded and dia-
betic wounded cell models [23, 25]. Previous experiments
on ADSCs have also shown that visible red (636 nm) and
near-infrared light (825 nm) at a fluence of 5 J/cm2 stimulate
the proliferation of these cells, and affected stem cell differ-
entiation through modulation of cellular metabolism and
redox status [27, 28]. Min et al. also showed that PBM at
830nm enhances the proliferation and viability of ADSCs
[29]. The objective of the present study was to determine
the effects of PBM at 660 or 830nm in regulating oxidative
stress in ADSCs in vitro with applications in diabetic wound
healing.
2. Materials and Methods
2.1. Cell Culture. This study was carried out on adipose-
derived stem cells (ADSCs) (ATCC® SCRC-4000TM) and
received ethical clearance from the Faculty of Health
Sciences, University of Johannesburg, Research Ethics
Committee (REC-01-28-2017). Four cell models, namely,
normal (N), wounded (W), diabetic (D), and diabetic
wounded (DW), were used. A diabetic model was achieved
by growing the cells in complete media with an additional
17mM/L D-glucose for more than two weeks to create a
hyperglycemic environment [23, 25]. A “wound” was created
on the cell monolayer prior to cell irradiation by using a ster-
ile 1mL pipette followed by a 30min incubation at 37°C, 85%
humidity, and 5% CO2 before irradiation [30].
2.2. Laser Irradiation. A continuous wave diode laser trans-
mitting at a wavelength of 660nm (Fremont, California,
USA, RGBlase, TECIRL-70G-650SMA) with a power output
of 102mW or at 830nm (Fremont, California, RGBlase,
TECIRL-70G-830) with a power output of 94mW was used
for irradiation. The laser beam was directed from above
towards cells via a fibre optic and had a spot size of 9.1 cm2,
thus producing a power density of 11.2mW/cm2 for
660 nm and a power density of 10.33mW/cm2 for 830nm.
In order to irradiate cells with a fluence of 5 J/cm2, cells were
irradiated in the dark for 446 s (45.39 J for 660nm) or 484 s
(45.59 J for 830 nm), respectively, in 3.4 cm2 diameter culture
dishes containing 6 × 105 cells in 1mL fresh culture media.
Postirradiation, cells were incubated for 24 h after which cell
viability, nuclear damage, and expression of AKT, FOXO1,
and enzymic antioxidants (SOD, CAT, and HMOX1) were
determined. Nonirradiated cells served as controls (0 J/cm2).
2.3. Cell Viability and Migration. Cell viability was deter-
mined by the trypan blue exclusion assay in all cell models
using 0.4% trypan blue (T8154, Sigma-Aldrich, South
Africa). About 10μL of trypan blue and 10μL of cells were
mixed and counted on the Invitrogen Countess™ II FL Auto-
mated Cell Counter. Migration of ADSCs in wounded
models with/without laser irradiation was captured over a
48 h period using an inverted light microscopy and the
AnalySIS getIT software (Olympus CKX41SF, Japan).
2.4. Hoechst Staining.Nuclear damage was determined by the
Hoechst stain. Briefly, 6 × 105 cells were cultured on sterile
cover slips in 3.4 cm diameter culture dishes and incubated
overnight, after which cells were irradiated with PBM at
660 or 830nm. Twenty-four hours after laser irradiation,
cells were incubated at room temperature with 1μg/mL
Hoechst 33258 (H21491, Invitrogen, Thermo Fisher
Scientific, South Africa) for 15min. The fluorescence signals
were examined using a Carl Zeiss Axio Observer Z1
(352Ex/461Em).
2.5. Enzyme-Linked Immunosorbent Assay (ELISA). ELISA
was used to determine enzymic antioxidants SOD, CAT,
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and HMOX1 in cultured cells. Cells were detached 24 h post-
irradiation (PBM at 660 or 830nm) using TrypLE™ Select
(12563-029, Gibco, Thermo Fisher Scientific, South Africa),
and 3 × 104 cells in 100μL media were seeded into 96-well
microplates (Corning®, Costar® 3596, Sigma-Aldrich, South
Africa) and allowed to attach. Cells were fixed in 8% parafor-
maldehyde for 15min at room temperature and washed three
times with PBS. Cells were permeabilized with 1% Triton X-
100 in PBS for 30min at room temperature and blocked in
2% blocking solution (10% bovine serum albumin (BSA) in
PBS) for 2 h at room temperature. Plates were washed and
incubated for 2 h with 1 : 50 primary antibody (mouse mono-
clonal IgG; Santa Cruz Biotechnology, SOD-1: sc-101523;
CAT: sc-271358; HMOX1: sc-136960; Anatech Instruments
(Pty) Ltd., South Africa). Plates were washed three times
and incubated for 2 h with 1 : 5,000 secondary antibody (goat
anti-mouse IgG-HRP, Santa Cruz Biotechnology, sc-2005,
Anatech Instruments (Pty) Ltd., South Africa). Following
rinsing, plates were incubated for 20min with 3,3′,5,5′-tet-
ramethylbenzidine (TMB) substrate and the reaction stopped
with 1M hydrochloric acid. Absorbance was read at 450 nm
(PerkinElmer, Victor3™ multiplate reader).
2.6. Immunofluorescence. To examine the presence of AKT
and FOXO1, 6 × 105 cells were cultured on sterile cover slips
for 12 h and irradiated at 660 or 830 nm. Cells were fixed 24 h
postirradiation for 15min in 4% formaldehyde at room tem-
perature, washed twice in PBS, and permeabilized for 15min
at room temperature (0.01% v/v Triton X-100 in PBS). Cells
were washed twice, blocked for 1 h (3% BSA in PBS), and
incubated for 2 h at room temperature with 1 : 100 primary
antibody (mouse monoclonal IgG; AKT: AHO-1112, Invitro-
gen, Thermo Fisher Scientific, South Africa; and rabbit
monoclonal IgG; FOXO1: mAb-2880, Cell Signaling Tech-
nology, South Africa). The cells were washed twice and incu-
bated for 2 h with 1 : 2,500 conjugated secondary antibody
(goat anti-mouse FITC: Santa Cruz Biotechnology, sc-2010,
Anatech Instruments (Pty) Ltd., South Africa). Nuclei were
stained with 300nM 4′,6-diamidino-2-phenylindole (DAPI;
Invitrogen, D1306, Thermo Fisher Scientific, South Africa)
and slides examined using the Carl Zeiss Axio Observer Z1
(FITC 494Ex/518Em and DAPI 358Ex/461Em).
2.7. Western Blotting. The Pierce™ BCA Protein Assay Kit
(23225, Thermo Fisher Scientific, South Africa) was used to
determine protein concentration. Cell lysates were diluted
to 1μg/μL in sample buffer (Laemmli 2× buffer; S3401,
Sigma-Aldrich, South Africa) and heated at 110°C for 5 to
7min. Protein samples (25μL) were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to an Immun-Blot PVDF membrane
(162-0177, Bio-Rad, South Africa) for 3 h at 60 volts using a
semidry blotter (B2529, Sigma-Aldrich, South Africa). Once
the protein was transferred, 5% BSA in Tris-buffered saline
(TBS) was used for blocking for 20min. Membranes were
incubated at 4°C overnight with primary antibody (mouse
monoclonal IgG; AKT: AHO-01112, Thermo Fisher Scien-
tific, South Africa; rabbit monoclonal IgG; FOXO1: mAb-
2880, Cell Signaling Technology, South Africa; and GAPDH:
sc-47724, Santa Cruz Biotechnology, Anatech Instruments
(Pty) Ltd., South Africa). After washing three times for
10min with 0.1% Tween-20 in TBS, membranes were incu-
bated with horseradish peroxidase-conjugated secondary
antibody (goat anti-mouse HRP: Santa Cruz Biotechnology,
sc-2005, Anatech Instruments (Pty) Ltd., South Africa). After
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Figure 1: Effect of photobiomodulation on cell viability in normal (N), wounded (W), diabetic (D), and diabetic wounded (DW) ADSCs
irradiated at a wavelength of 660 or 830 nm with a fluence of 5 J/cm2. Irradiated N, W, D, and DW cells showed a significant increase in
cell viability as compared to nonirradiated cells. Data is expressed as the ±SEM (n = 3). Significant probability is shown as ∗P ≤ 0:05 and
∗∗P ≤ 0:01.
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Figure 2: (a) Migration of ADSCs in a wounded cell model irradiated at a wavelength of 660 or 830 nm with a fluence of 5 J/cm2. Cells in the
irradiated models migrated faster towards the center and more cells covered the central scratch at 48 h. (b) Migration of ADSCs in a diabetic
wounded cell model irradiated at a wavelength of 660 or 830 nm with a fluence of 5 J/cm2. Cell migration in irradiated cell models was rapid
and closed almost 90% of the scratch wound by 48 h.
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incubated in the dark for 5min with 1% 3,3′-diaminobenzi-
dine (DAB) and 0.3% hydrogen peroxide in 5mL PBS;
developed bands were scanned. ImageJ software (National
Institutes of Health, USA) was used for quantitative analysis
of scanned densitometric values as ratios to GAPDH (used as
a loading control).
2.8. Statistical Analysis. Data is represented as the standard
error of the mean (SEM) of three repeats done in duplicate
(n = 3). Statistical significance was analyzed using SigmaPlot
version 13.0. Significant differences between irritated and
control cells were determined by the Student t-test and
between wavelengths using the one-way analysis of variance
(ANOVA). Significant probabilities are shown as ∗P ≤ 0:05,
∗∗P ≤ 0:01, and ∗∗∗P ≤ 0:001.
3. Results
3.1. Cell Viability and Migration. Figure 1 shows the viability
of ADSCs in nonirradiated and irradiated normal (N),
wounded (W), diabetic (D), and diabetic wounded (DW)
models as determined by the trypan blue exclusion assay. A
significant increase (P < 0:05) in cell viability was observed
at both wavelengths in all irradiated cells. Comparison of
the wavelengths showed that irradiation of W, D, and DW
cells at 660 nm produced a significant increase (P < 0:05) as
compared to the same cells irradiated at 830 nm.
Figures 2(a) and 2(b) show the morphology and migra-
tion of wounded and diabetic wounded ADSC models.
Irradiated cells appeared normal in morphology (regular
spindle-shaped structure) with increased cell migration
towards the central scratch over time, and complete wound
closure at 48 h. Nonirradiated models showed poor cell
migration towards the central scratch and a delay in wound
closure at 48 h.
3.2. Nuclear Damage Assessment by Hoechst Staining.
Nuclear damage in irradiated and nonirradiated cells was
assessed 24h postirradiation (Figure 3). Nonirradiated cells
showed irregular-shaped nuclei with hollow centers and frag-
mented nuclei, whereas irradiated models showed clear
spherical-shaped nuclei without any nuclear fragmentation.
3.3. AKT and FOXO1 Analysis. Figures 4 and 5 represent the
effect of PBM on AKT and FOXO1, respectively, by
immunofluorescence. The increased oxidative stress under
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Figure 3: Nuclear damage assessment by Hoechst 33258 staining in ADSCs in normal, wounded, diabetic, and diabetic wounded cell models
irradiated at a wavelength of 660 and 830 nm with a fluence of 5 J/cm2 and incubated for 24 h. In the nonirradiated groups, irregular-shaped
nuclei, fragmented nuclei, and apoptotic cells (red arrow) were observed. In nonirradiated diabetic and diabetic wounded cells, there is an
increase in the number of apoptotic cells and nuclear condensation. On the other hand, the irradiated groups showed uniformly stained
nuclei, signifying dense nuclei without any fragmentation (red arrows). Magnification = × 100.
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hyperglycemic conditions resulted in the diminished pres-
ence of AKT and increased presence of FOXO1 in diabetic
and diabetic wounded cell models. Upon treatment with
PBM at 660 or 830 nm, the fluorescent signal of AKT
increased and FOXO1 decreased. Western blotting
(Figure 6(b)) showed a significant increase in AKT levels in
all irradiated cell models (P < 0:05). Comparison of the
wavelengths showed that irradiation of N cells at 660nm
produced a significant increase in AKT levels (P < 0:01) as
compared to the same cells irradiated at 830 nm, whereas
W (P < 0:01), D (P < 0:01), and DW (P < 0:05) cells showed
a significant decrease at 660nm. Similarly Figure 6(c) shows
a significant decrease (P < 0:01) in FOXO1 levels in all irradi-
ated cell models. One-way ANOVA analysis comparison
between wavelengths 660 nm and 830 nm showed that irradi-
ation of N and D cell models at 660nm showed a significant
increase in FOXO1 levels (P < 0:05 and P < 0:01, respec-
tively), whereas W (P < 0:05) and DW (P < 0:01) cells
showed a significant decrease in FOXO1 levels at 660 nm
compared to the same cells at 830 nm.
3.4. Expression of Enzymic Antioxidants. Figure 7 shows the
levels of enzymic antioxidants (SOD, CAT, and HMOX1)
24 h postirradiation. There was a significant increase in anti-
oxidant levels in all the cell models (N, W, D, and DW)
irradiated at 660 or 830nm (P < 0:05). Comparison of the
wavelengths showed that irradiation of N, W, D, and DW
cells at 830nm produced a significant increase in SOD
(P < 0:05, P < 0:001, P < 0:05, and P < 0:01, respectively)
and CAT (P < 0:01, P < 0:001, P < 0:05, and P < 0:001,
respectively). HMOX1 levels in N, W, and DW cells irradi-
ated at 830nm were significantly increased compared to the
same cells at 660nm (P < 0:001, P < 0:05, and P < 0:001,
respectively).
4. Discussion
PBM is a noninvasive method in which light at a particular
wavelength and fluence is used to treat inflammatory diseases
and stimulate tissue regeneration, resulting in the accelerated
repair of chronic wounds [25, 31]. It has been shown that
PBM effectively alters redox potential and intracellular ROS
production [32]. Cell migration and proliferation are impor-
tant for successful wound healing. Various studies have
shown that PBM effectively stimulates cell proliferation and
migration of fibroblasts and keratinocytes, as well as epithe-
lial, endothelial, and mesenchymal cells. The wavelength
range, fluence, and the time duration of irradiation influence
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Figure 4: Effect of photobiomodulation on AKT in normal, wounded, diabetic, and diabetic wounded ADSCs irradiated at a wavelength of
660 and 830 nm with a fluence of 5 J/cm2. AKT is stained green with FITC, and nuclei are stained blue with DAPI. Both the irradiated and
nonirradiated groups displayed positive staining for AKT proteins. Irradiated cells expressed more AKT protein compared to the
nonirradiated groups. Red arrows indicate the presence of AKT. Magnification = × 100.
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the rate of migration and proliferation. Hawkins and
Abrahamse found that PBM (at 632.8 nm with 2.5, 5, and
16 J/cm2) significantly increased human skin fibroblast
(HSF) migration and proliferation. They also found that a
lower fluence (2.5 and 5 J/cm2) is more effective than a higher
fluence (16 J/cm2) in stimulating cell proliferation and
wound healing. Many preclinical studies reported the impor-
tance of ADSCs in regulating wound healing, which is mostly
through the regulation of angiogenesis and matrix formation
[17]. Increased new vessel formation will enhance matrix
deposition that will promote wound closure. Another study
by Heo and colleagues showed that PBM at 660 nm with
3 J/cm2 attenuates oxidative stress by stimulating the expres-
sion of brain-derived neurotrophic factor (BDNF) via ERK
and CREB signaling in the mouse hippocampus [33]. PBM
(808nm) induces the differentiation of human umbilical cord
mesenchymal stem cells (hUC-MSCs) to neuronal cells and it
also elevates nitric oxide to promote vasodilation [34].
PBM along with growth factors in complete media stim-
ulates the differentiation of ADSCs into smooth muscle cells.
Under normal conditions, PBM increases ROS generation,
whereas under conditions of oxidative stress, PBM reduces
ROS generation and apoptosis [35]. PBM treatment also
stimulates wound healing in fibroblast cells by inhibiting
ROS production and promotes cell proliferation by activating
the ERK1/2 pathway to hasten wound closure [36]. In a sim-
ilar study, irradiation of human skin fibroblasts at 660 or
830 nm with 5 J/cm2 showed that raised oxidative stress was
reversed in diabetic and diabetic wounded fibroblast cell
models, and there were increased levels of SOD, CAT, and
HMOX1 [37]. Consistently, our experiments confirmed that
PBM at 660/830 nm reduces diabetic-induced oxidative
stress. The main mechanism of action of PBM is the absorp-
tion of photons by the respiratory chain mainly cytochrome c
oxidase (by the heme and copper subunits). Once light gets
absorbed, it upregulates mitochondrial membrane potential,
cyclic AMPs, nitric oxide, and ROS that lead to the activation
of various signaling pathways and transcription factors to
stimulate the antioxidant defence system [38]. In this study,
we found that PBM at 660 or 830nm significantly increased
the levels of the antioxidant enzymes (SOD, CAT, and
HMOX1).
Our results showed that PBM at 660 and 830 nm signifi-
cantly promotes wound closure by increasing ADSC
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Figure 5: Effect of photobiomodulation on FOXO1 levels in normal, wounded, diabetic, and diabetic wounded ADSCs irradiated at a
wavelength of 660 and 830 nm with a fluence of 5 J/cm2. FOXO1 is stained green with FITC, and nuclei are stained blue with DAPI. Both
the irradiated and nonirradiated groups displayed positive staining for FOXO1 proteins. Irradiated cells expressed less FOXO1 compared
to the nonirradiated groups. In the nonirradiated groups, there was an increase in nuclear translocation of FOXO1 in diabetic and diabetic
wounded models compared to their normal counterparts. This is due to the increase in oxidative stress induced by growing cells under
hyperglycemic conditions. Red arrows indicate the presence of FOXO1. Magnification = × 100.
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migration towards the wound edge. Our results also showed a
significant increase in cell viability, corresponding to the
results observed in a similar study by de Villiers et al. [31],
who observed an increase in cell viability in isolated ADSCs
and a commercial ADSC cell line irradiated at a wavelength
of 636nm and a fluence of 5 J/cm2. Ebrahimpour-
Malekshah et al. irradiated diabetic mice with an infected
(MRSA) ischemic wound with or without transplanted
ADSCs at 890nm (power 80W; pulse frequency 80Hz;
pulsed duration 180ns; duration of exposure 200 s; power
density 0.001W/cm2; and energy density 0.2 J/cm2) 6 days
per week for 16 days [39]. There was a significant decrease
in microbial flora and inflammatory response and a signifi-
cant increase in wound closure rate and strength and angio-
genesis in all treated mice; however, it was found that PBM
together with transplanted ADSCs showed superior results
as compared to PBM and ADSC transplantation alone [39].
Wound healing is a well-organized sequential process
that requires various cells, growth factors, cell-cell interac-
tions, and signaling pathways. The AKT signaling pathway
is important for cell survival, cell growth, cell proliferation/-
migration, angiogenesis, and regeneration. Similarly,
Forkhead Box O1 (FOXO1) plays an important role in
determining apoptosis and cell death and maintaining redox
balance. An in vitro study using fibroblasts revealed that the
knocking down of the FOXO1 gene increases cell prolifera-
tion andmigration [40]. In diabetes, impaired healing is asso-
ciated with the over expression of FOXO genes. In normal
mice, FOXO1 promotes cutaneous wound healing by block-
ing oxidative stress through the TGF-β1 signaling pathway
[41]. Mi et al. found that icariin promotes wound healing
by increasing the migration and proliferation of keratino-
cytes by upregulating the AKT signaling pathway [42]. Our
results show that PBM of ADSCs at 660 and 830 nm signifi-
cantly increased AKT levels and attenuated FOXO1 levels,
which hastened wound closure and enhanced the migration
of cells, as was observed in the scratch wound assay. This
was also evident in the diabetic model whereby ADSCs were
grown under hyperglycemic conditions.
Changes in glucose metabolism may lead to tissue dam-
age. Hyperglycemia increases the formation of free radicals,
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Figure 6: Effect of photobiomodulation on AKT and FOXO1 in normal (N), wounded (W), diabetic (D), and diabetic wounded (DW)
ADSCs irradiated at a wavelength of 660 and 830 nm with a fluence of 5 J/cm2. GAPDH was used as a loading control. L1: normal
(0 J/cm2); L2: wounded (0 J/cm2); L3: diabetic (0 J/cm2); L4: diabetic wounded (0 J/cm2); L5: normal (5 J/cm2); L6: wounded (5 J/cm2); L7:
diabetic (5 J/cm2); and L8: diabetic wounded (5 J/cm2). (a) Representative blots. (b, c) Quantification of the ratio of the intensity of target
protein divided by the loading control protein. Irradiated N, W, D, and DW cells showed a significant increase in AKT levels (b) and
decreased FOXO1 levels (c) as compared to the nonirradiated cells. Data is expressed as the ±SEM (n = 3). Significant probabilities
compared to the nonirradiated groups are shown as ∗P ≤ 0:05, ∗∗P ≤ 0:01, and ∗∗∗P ≤ 0:001.
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directly or indirectly damage tissue and macromolecules.
Once macromolecules (proteins, lipids, and DNA) are dam-
aged, the normal cell cycle gets arrested which results in cell
death. In our study, we found that the diabetic models
showed fragmented/irregular-shaped nuclei suggesting cell
death; however, this was not evident in irradiated cells, sug-
gesting that PBM has a protective mechanism on these cells.
Removal of free radicals/ROS and inhibition of AGEs may
serve as a promising treatment for diabetic complications,
e.g., antioxidant therapy well known for treating various dia-
betic complications. It is well known that a chronic hypergly-
cemic state is deleterious to cells and delays the wound
healing process. This is due to an imbalance in the redox
state, i.e., increased free radical production and reduced anti-
oxidant activities. The oxidative stress condition promotes
dysfunction of endothelial and smooth muscle cells that
directly affect angiogenesis, thereby wound healing gets
delayed. Antioxidants play an important role in scavenging
free radicals and maintaining normal redox balance. Mi
and colleagues [42] found that PBM at 632 nm with/without
quercetin enhanced cutaneous wound healing in diabetic rats
by elevating antioxidant levels and increasing the rate of
migration/proliferation of fibroblasts, and accelerated matrix
deposition [43]. Similar to this, our results have showed that
PBM at 660 and 830nm promotes in vitro wound healing by
increasing the levels of antioxidants (SOD, CAT, and
HMOX1) in ADSCs. When comparing the two wavelengths
used in this study, a wavelength of 830nm is more effective
in attenuating oxidative stress. It was more effective in
increasing AKT and antioxidant levels as compared to a
wavelength of 660nm. George et al. were also able to show
that irradiation of ADSCs at 830nm significantly upregu-
lated the expression of the gene SOD1, along with other genes
involved in redox mechanisms (GPx), glycolytic pathways
(HIF-1α, LDHB, and PKM2), and mitochondrial activity
(TFAM) [28].
5. Conclusions
In conclusion, this study has demonstrated that PBM can
activate AKT signaling in ADSCs to promote wound healing
under hyperglycemic conditions. Modulation of the AKT/-
FOXO1 signaling pathway might alter redox balance that
contributes to delayed wound healing in diabetes. PBM effec-
tively maintains normal redox balance and increases antiox-
idant levels by stimulating the AKT signaling pathways.
From this study, it is clear that irradiation (660 and 830nm
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Figure 7: Effect of photobiomodulation on enzymic antioxidants in normal (N), wounded (W), diabetic (D), and diabetic wounded (DW)
ADSCs irradiated at a wavelength of 660 and 830 nm with a fluence of 5 J/cm2. Data is expressed as the ±SEM (n = 3). Significant
probabilities compared to the nonirradiated groups are shown as ∗P ≤ 0:05, ∗∗P ≤ 0:01, and ∗∗∗P ≤ 0:001.
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However, a wavelength of 830nm was more effective in
attenuating oxidative stress in ADSCs, grown under physio-
logical glucose concentrations and under hyperglycemic
conditions than 660nm.
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